Literature DB >> 17261971

Diabetes insipidus: clinical and basic aspects.

Joseph A Majzoub1, Abhinash Srivatsa.   

Abstract

Water homeostasis in the body is finely balanced by the release of the antidiuretic hormone vasopressin and the stimulation of thirst. Vasopressin acts in the kidneys to concentrate urine and reduce plasma osmolality. Diabetes insipidus is a disorder of water balance characterized by a failure to concentrate urine. There are two types of diabetes insipidus: central and nephrogenic. Central diabetes insipidus is caused by insufficient production of vasopressin, while nephrogenic diabetes insipidus is caused by an impaired response of the kidneys to vasopressin. Patients with central diabetes insipidus respond to treatment with vasopressin or its synthetic analogue, desmopressin; however, caution should be utilized in treating infants with vasopressin or analogues-infants can be treated successfully with fluids alone. Treatment of nephrogenic diabetes insipidus involves removing the underlying cause, if possible, reducing solute load or therapy with a diuretic agent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17261971

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  7 in total

1.  Mutations in the AVPR2, AVP-NPII, and AQP2 genes in Turkish patients with diabetes insipidus.

Authors:  Duygu Duzenli; Emel Saglar; Ferhat Deniz; Omer Azal; Beril Erdem; Hatice Mergen
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

2.  Evaluation of electrocardiographic parameters in patients with diabetes insipidus.

Authors:  Ferhat Deniz; Alper Kepez; Seyit Ahmet Ay; Okan Ergogan; Kamil Baskoy; Mustafa Nuri Guncıkan; Zekeriya Dogan; Arif Yonem
Journal:  Wien Klin Wochenschr       Date:  2015-10-14       Impact factor: 1.704

3.  Case 1: polyuria at the magic kingdom.

Authors:  Tania Cellucci; Shayna Zelcer; Farid H Mahmud
Journal:  Paediatr Child Health       Date:  2008-09       Impact factor: 2.253

4.  The role of hyperosmotic stress in inflammation and disease.

Authors:  Chad Brocker; David C Thompson; Vasilis Vasiliou
Journal:  Biomol Concepts       Date:  2012-08

Review 5.  Angiotensin inhibition and longevity: a question of hydration.

Authors:  Simon N Thornton
Journal:  Pflugers Arch       Date:  2010-12-17       Impact factor: 3.657

6.  A novel disease-causing mutation in AVPR2: Q96H.

Authors:  Mathieu Lemaire; David Chitayat; Denis F Geary; Daniel G Bichet; Christoph Licht
Journal:  NDT Plus       Date:  2008-10-31

7.  Desmopressin lyophilisate for the treatment of central diabetes insipidus: first experience in very young infants.

Authors:  Kathleen De Waele; Martine Cools; Ann De Guchtenaere; Johan Van de Walle; Ann Raes; Sara Van Aken; Kris De Coen; Piet Vanhaesebrouck; Jean De Schepper
Journal:  Int J Endocrinol Metab       Date:  2014-10-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.